Congratulations to Yossi Tam who was awarded the NIH/NCATS Director's Award for extraordinary leadership in the discovery and development of first-in-class peripheral CB1 receptor antagonist for therapeutic use in Metabolic Syndrome
Share on Facebook
Share on Twitter
I'm busy working on my blog posts. Watch this space!